OutPerformDaily

  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks

Lost Password?
Amazon vs. Costco: Which Stock Is a Better Buy?

Amazon vs. Costco: Which Stock Is a Better Buy?

Cross Staff Loads Up on 289,000 Shares of AKRE

Cross Staff Loads Up on 289,000 Shares of AKRE

Prediction: This Artificial Intelligence (AI) Stock Will Join Nvidia, Apple, and Alphabet in the $3 Trillion Club Before 2028

The billion-dollar infrastructure deals powering the AI boom

AI Boom May Be Creating Hidden Risks In Housing Market

Cisco’s Secure AI Factory Links Sovereign Data Push To Valuation Story

OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
OutPerformDaily
  • Tech Stocks
  • Cannabis Stocks
  • Index Funds
  • International
  • Short
  • Stock Picks
3rdPartyFeeds • News

Trump defends tweet suggesting delay in 2020 election after political firestorm erupts

July 30, 2020

President Trump on Thursday defended his earlier tweet suggesting the Nov. 3 election should be postponed, repeating his unsupported contention that widespread...

3rdPartyFeeds

Alphabet’s Revenue Fell for First Time Ever as Covid Hit Ads

July 30, 2020

(Bloomberg) -- Alphabet Inc.’s revenue growth machine ground to a halt for the first time in the company’s two-decade history stopped by the coronavirus...

3rdPartyFeeds • News

MarketWatch First Take: Pandemic? Antitrust? No worries for Big Tech, which racked up $200 billion in sales anyway

July 30, 2020

Amid a global pandemic and concerted antitrust scrutiny, the four giants of Big Tech are just getting bigger.

Read More...

3rdPartyFeeds

Amazon promised to spend its profit amid pandemic, but ended up with record earnings anyway

July 30, 2020

Amazon.com Inc. Chief Executive Jeff Bezos promised to spend all the additional profits his company made from a huge boost in sales related to the COVID-19...

3rdPartyFeeds

Remdesivir maker Gilead Sciences sees 10% drop in second-quarter sales as demand for non-coronavirus drugs falls

July 30, 2020

Gilead Sciences' sales fell 10% in the second quarter from a year earlier as the coronavirus pandemic weakened demand for some of its drugs, including some of...

3rdPartyFeeds

Alphabet reports first revenue decline in company history

July 30, 2020

Alphabet's Q2 earnings are expected to be hit hard by the effects of the pandemic alongside a maturing digital ad market. Read more...

3rdPartyFeeds

Apple posts blowout third quarter, with sales up 11% despite coronavirus disruptions

July 30, 2020

The company declined to issue guidance for the second quarter in a row, but said on a call with analysts that it expects iPhone supply in the fall to be...

3rdPartyFeeds

Why PayPal Stock Rose to a New All-Time High Today

July 30, 2020

Shares of PayPal Holdings (NASDAQ: PYPL) climbed 4.3% to a new closing high of $192.51 on Thursday, following the online payment processing giant's strong...

3rdPartyFeeds

Amazon Reports $5.2B in Net Income, Cruises Past Estimates

July 30, 2020

Everyone knew Amazon would do well. But even ceo Jeff Bezos seems a little surprised it did this well. Read More...

3rdPartyFeeds

Ford beats Wall Street earnings expectations after coronavirus shuttered factories

July 30, 2020

The company was profitable, reported less operational losses than expected and has already started repaying credits lines it drew down earlier this year to...

Previous 1 … 5,870 5,871 5,872 5,873 5,874 … 8,454 Next
Indices by TradingView

Categories

  • 3rdPartyFeeds
  • Cannabis Stocks
  • Index Funds
  • International
  • News
  • Short
  • Stock Picks
  • Tech Stocks
  • Uncategorized
Indices by TradingView
While subscribers receive the benefit of Outperformdaily opinions, none of the information contained therein constitutes a recommendation from Outperformdaily that any particular security, portfolio of securities, transaction, option, or investment strategy is suitable for any specific person. You further understand that we will not advise you personally concerning the nature, potential, value or suitability of any particular security, portfolio of securities, transaction, investment strategy or other matter. To the extent any of the information contained in Outperformdaily may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person. Outperformdaily’s past results are not necessarily indicative of future performance. All investments are subject to loss. Our employees and writters typically personally invest in all recommendations, but they are not obligated too. Our employees and writters are prohibited from taking an opposite position from which they write about.